Antje Mevius
Overview
Explore the profile of Antje Mevius including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lehnerer S, Herdick M, Mevius A, Grittner U, Gansel P, Joeres L, et al.
Sci Rep
. 2025 Feb;
15(1):6687.
PMID: 39994434
Myasthenia gravis (MG) is a neuromuscular disorder resulting in exertion-dependent muscle fatigability. Affecting all age groups MG is a chronic disease with unpredictable fluctuations and a range of symptom expression...
2.
Mevius A, Lutter J, Karl F, Tuffy L, Schochter F, Fuchs A, et al.
Oncol Res Treat
. 2024 Nov;
48(3):92-101.
PMID: 39602910
Introduction: The aim of this study was to describe the epidemiology of primary advanced or recurrent endometrial cancer and the outcomes from real-world treatment patterns of patients affected in Germany...
3.
Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases
Weisser B, Wassmann S, Predel H, Schmieder R, Gillessen A, Wilke T, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Jul;
10(8):686-693.
PMID: 39085036
Aims: Our study aimed to assess whether a single pill concept (SPC) is superior to a multi-pill concept (MPC) in reducing cardiovascular (CV) events, all-cause death, and costs in CV...
4.
Heidbrede T, Mevius A, Kessel S, Wilke T, Maywald U, Thiem A
J Dtsch Dermatol Ges
. 2023 Jun;
21(6):611-621.
PMID: 37338849
No abstract available.
5.
Mevius A, Joeres L, Gille P, Molzan M, Foskett N, Wilke T, et al.
Brain Commun
. 2023 May;
5(3):fcad145.
PMID: 37180995
Status epilepticus is a life-threatening emergency, and to date, few studies have reported on its long-term treatment and outcomes. This study aimed to estimate the incidence, the treatment and outcomes,...
6.
Heidbrede T, Mevius A, Kessel S, Wilke T, Maywald U, Thiem A
J Dtsch Dermatol Ges
. 2023 Apr;
21(6):611-619.
PMID: 37073599
Background And Objectives: Psoriasis is a common skin disorder with a high physical and psychological burden for patients. Up to 30% of the patients are candidates for a systemic treatment....
7.
Schmieder R, Wassmann S, Predel H, Weisser B, Blettenberg J, Gillessen A, et al.
Hypertension
. 2023 Mar;
80(5):1127-1135.
PMID: 36987918
Background: Single-pill combination improves adherence and persistence to medication in hypertension. It remains unclear whether this also reduces cardiovascular outcomes and all-cause mortality. We analyzed whether single-pill combinations are superior...
8.
Mevius A, Jores L, Biskup J, Heidbrede T, Mahic M, Wilke T, et al.
Neuromuscul Disord
. 2023 Mar;
33(4):324-333.
PMID: 36921445
Myasthenia gravis (MG) is a rare, chronic autoimmune disease with symptoms of fluctuating muscular weakness and fatigability. The aim of this retrospective cohort study was to estimate the prevalence and...
9.
Mevius A, Karl F, Wacker M, Welte R, Krenzer S, Link T, et al.
J Cancer Res Clin Oncol
. 2022 Jul;
149(5):1929-1939.
PMID: 35840862
Purpose: Endometrial cancer (EC) is the sixth most common malignancy among females worldwide. Due to limited therapeutic options, treatment of advanced or recurrent disease is associated with poor outcomes. The...
10.
Mevius A, Heidbrede T, Gille P, Pannen H, Wilke T
Ger Med Sci
. 2022 Feb;
19:Doc15.
PMID: 35110980
Osteoporosis (OP) and its associated fractures have a significant impact on patients' quality of life and are impacting their morbidity and mortality. For OP patients at high risk of fracture,...